[PHARMA] QoQ TTM Result on 31-Dec-2002 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
10-Apr-2003
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2002
Quarter
31-Dec-2002 [#4]
Profit Trend
QoQ- -3.54%
YoY- 21.22%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Revenue 595,774 596,928 599,086 585,237 594,966 578,889 553,176 5.06%
PBT 59,464 62,072 65,591 61,170 64,797 58,312 52,093 9.21%
Tax -21,424 -23,185 -23,946 -23,829 -26,084 -24,033 -22,413 -2.96%
NP 38,040 38,887 41,645 37,341 38,713 34,279 29,680 17.97%
-
NP to SH 38,040 38,887 41,645 37,341 38,713 34,279 29,680 17.97%
-
Tax Rate 36.03% 37.35% 36.51% 38.96% 40.25% 41.21% 43.02% -
Total Cost 557,734 558,041 557,441 547,896 556,253 544,610 523,496 4.30%
-
Net Worth 211,489 194,744 192,761 179,444 172,829 159,457 167,817 16.65%
Dividend
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Div 8,506 3,744 3,744 3,744 5,002 3,750 3,750 72.54%
Div Payout % 22.36% 9.63% 8.99% 10.03% 12.92% 10.94% 12.64% -
Equity
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Net Worth 211,489 194,744 192,761 179,444 172,829 159,457 167,817 16.65%
NOSH 100,232 99,869 100,396 99,691 50,095 49,986 49,945 59.03%
Ratio Analysis
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
NP Margin 6.38% 6.51% 6.95% 6.38% 6.51% 5.92% 5.37% -
ROE 17.99% 19.97% 21.60% 20.81% 22.40% 21.50% 17.69% -
Per Share
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
RPS 594.39 597.71 596.72 587.05 1,187.67 1,158.09 1,107.56 -33.93%
EPS 37.95 38.94 41.48 37.46 77.28 68.58 59.42 -25.81%
DPS 8.50 3.75 3.73 3.76 10.00 7.50 7.50 8.69%
NAPS 2.11 1.95 1.92 1.80 3.45 3.19 3.36 -26.64%
Adjusted Per Share Value based on latest NOSH - 99,691
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
RPS 41.34 41.42 41.57 40.61 41.28 40.17 38.38 5.07%
EPS 2.64 2.70 2.89 2.59 2.69 2.38 2.06 17.96%
DPS 0.59 0.26 0.26 0.26 0.35 0.26 0.26 72.59%
NAPS 0.1467 0.1351 0.1337 0.1245 0.1199 0.1106 0.1164 16.66%
Price Multiplier on Financial Quarter End Date
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Date 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 28/06/02 29/03/02 -
Price 4.55 4.07 3.64 3.80 7.68 7.32 7.32 -
P/RPS 0.77 0.68 0.61 0.65 0.65 0.63 0.66 10.81%
P/EPS 11.99 10.45 8.78 10.15 9.94 10.67 12.32 -1.79%
EY 8.34 9.57 11.40 9.86 10.06 9.37 8.12 1.79%
DY 1.87 0.92 1.02 0.99 1.30 1.02 1.02 49.73%
P/NAPS 2.16 2.09 1.90 2.11 2.23 2.29 2.18 -0.61%
Price Multiplier on Announcement Date
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Date 14/11/03 19/08/03 20/05/03 10/04/03 22/11/02 26/08/02 21/05/02 -
Price 5.00 4.73 3.69 3.62 7.36 7.86 7.86 -
P/RPS 0.84 0.79 0.62 0.62 0.62 0.68 0.71 11.85%
P/EPS 13.17 12.15 8.90 9.66 9.52 11.46 13.23 -0.30%
EY 7.59 8.23 11.24 10.35 10.50 8.72 7.56 0.26%
DY 1.70 0.79 1.01 1.04 1.36 0.95 0.95 47.34%
P/NAPS 2.37 2.43 1.92 2.01 2.13 2.46 2.34 0.85%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment